Lv1
6 积分 2025-06-30 加入
Multi-objective antibody design and optimization using machine learning
1小时前
待确认
Metabolic heterogeneity in cancer
27天前
已完结
Harnessing alternative splicing for off-the-shelf mRNA neoantigen vaccines in hepatocellular carcinoma
5个月前
已完结
AI-driven protein design
8个月前
已完结
Involvement of TIGIT in Natural Killer Cell Exhaustion and Immune Escape in Patients and Mouse Model With Liver Echinococcus multilocularis Infection
8个月前
已完结
Abstract 3118: IBI3026, a first-in-class anti-PD-1/IL-12 fusion protein, demonstrates the potential to be a new immuno-oncology therapy by releasing the break in immune response and strongly activating T and NK cells in the tumor microenvironment
9个月前
已完结
IL-2Rα-biased agonist enhances antitumor immunity by invigorating tumor-infiltrating CD25+CD8+ T cells
10个月前
已完结
皖公网安备34019202002308
